Chemical Compound Review:
Jatrosom (1R)-2-phenylcyclopropan-1- amine
Synonyms:
Parnate, Transamine, tranylcypromine, Sulfate, Tranylcypromine, trans-2-Phenylcyclopropylamine, ...
Härtter,
Tybring,
Friedberg,
Weigmann,
Hiemke,
Fowler,
Volkow,
Wang,
Pappas,
Logan,
Shea,
Alexoff,
MacGregor,
Schlyer,
Zezulkova,
Wolf,
McGrath,
Stewart,
Fava,
Trivedi,
Wisniewski,
Nierenberg,
Thase,
Davis,
Biggs,
Shores-Wilson,
Luther,
Niederehe,
Warden,
Rush,
Taavitsainen,
Juvonen,
Pelkonen,
Pei,
Zetterström,
Sprakes,
Tordera,
Sharp,
- Yohimbine- and tranylcypromine-induced postural hypotension. Lin, S.C., Hsu, T., Fredrickson, P.A., Richelson, E. The American journal of psychiatry. (1987)
- Cardiac myonecrosis in hypertensive crisis associated with monoamine oxidase inhibitor therapy. Liu, L.X., Rustgi, A.K. Am. J. Med. (1987)
- Monoamine oxidase and catechol-O-methyltransferase activity in hamster and rat insulinomas. Feldman, J.M., Reintgen, D.S., Seigler, H.F. Diabetologia (1979)
- Interactions of levodopa with inhibitors of monoamine oxidase and L-aromatic amino acid decarboxylase. Teychenne, P.F., Calne, D.B., Lewis, P.J., Findley, L.J. Clin. Pharmacol. Ther. (1975)
- Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications. Lee, M.G., Wynder, C., Schmidt, D.M., McCafferty, D.G., Shiekhattar, R. Chem. Biol. (2006)
- Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine. Cowdry, R.W., Gardner, D.L. Arch. Gen. Psychiatry (1988)
- Cerebral correlates of depressed behavior in rats, visualized using 14C-2-deoxyglucose autoradiography. Caldecott-Hazard, S., Mazziotta, J., Phelps, M. J. Neurosci. (1988)
- Tranylcypromine versus imipramine in anergic bipolar depression. Himmelhoch, J.M., Thase, M.E., Mallinger, A.G., Houck, P. The American journal of psychiatry. (1991)
- Treatment of melancholia with tranylcypromine. McGrath, P.J., Quitkin, F.M., Harrison, W., Stewart, J.W. The American journal of psychiatry. (1984)
- Rapid response of severe obsessive-compulsive disorder to tranylcypromine. Jenike, M.A. The American journal of psychiatry. (1981)
- Brain monoamine oxidase A inhibition in cigarette smokers. Fowler, J.S., Volkow, N.D., Wang, G.J., Pappas, N., Logan, J., Shea, C., Alexoff, D., MacGregor, R.R., Schlyer, D.J., Zezulkova, I., Wolf, A.P. Proc. Natl. Acad. Sci. U.S.A. (1996)
- Enhancement of platelet aggregation by tranylcypromine in mouse cerebral microvessels. Rosenblum, W.I., El-Sabban, F. Circ. Res. (1978)
- A parkinsonian syndrome induced in the goldfish by the neurotoxin MPTP. Pollard, H.B., Dhariwal, K., Adeyemo, O.M., Markey, C.J., Caohuy, H., Levine, M., Markey, S., Youdim, M.B. FASEB J. (1992)
- Tranylcypromine and 15-hydroperoxyarachidonate affect arachidonic acid release in addition to inhibition of prostacyclin synthesis in calf aortic endothelial cells. Hong, S.L., Carty, T., Deykin, D. J. Biol. Chem. (1980)
- A case report of successful treatment of dysmorphophobia with tranylcypromine. Jenike, M.A. The American journal of psychiatry. (1984)
- Evidence concerning the involvement of 5-hydroxytryptamine in the locomotor activity produced by amphetamine or tranylcypromine plus L-DOPA. Green, A.R., Kelly, P.H. Br. J. Pharmacol. (1976)
- Effects of tranylcypromine stereoisomers, clorgyline and deprenyl on open field activity during long term lithium administration in rats. Smith, D.F. Psychopharmacology (Berl.) (1976)
- Enhanced 5-hydroxytryptamine-mediated behavioural responses in rats following repeated electroconvulsive shock: relevance to the mechanism of the antidepressive effect of electroconvulsive therapy. Costain, D.W., Green, A.R., Grahame-Smith, D.G. Psychopharmacology (Berl.) (1979)
- Pharmacokinetics of tranylcypromine in patients who are depressed: relationship to cardiovascular effects. Mallinger, A.G., Edwards, D.J., Himmelhoch, J.M., Knopf, S., Ehler, J. Clin. Pharmacol. Ther. (1986)
- Formation and metabolism of catecholestrogens in depressed patients. Banger, M., Hiemke, C., Knuppen, R., Ball, P., Haupt, M., Wiedemann, K. Biol. Psychiatry (1990)
- Monoamine oxidase inhibitors: nature of their interaction with rabbit pancreatic islets to alter insluin secretion. Feldman, J.M., Chapman, B. Diabetologia (1975)
- Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Altar, C.A., Whitehead, R.E., Chen, R., Wörtwein, G., Madsen, T.M. Biol. Psychiatry (2003)
- Tranylcypromine lowers human platelet MAO B activity but not concentration. Fritz, R.R., Malek-Ahmadi, P., Rose, R.M., Denney, R.M., Abell, C.W. Biol. Psychiatry (1983)
- Lack of effect of chronic antidepressant treatment on Gs and Gi alpha-subunit protein and mRNA levels in the rat cerebral cortex. Emamghoreishi, M., Warsh, J.J., Sibony, D., Li, P.P. Neuropsychopharmacology (1996)
- Relationship between catechol-O-methyltransferase and phenolsulfotransferase in the metabolism of dopamine in the rat brain. Buu, N.T. J. Neurochem. (1985)
- Tranylcypromine Versus Venlafaxine Plus Mirtazapine Following Three Failed Antidepressant Medication Trials for Depression: A STAR*D Report. McGrath, P.J., Stewart, J.W., Fava, M., Trivedi, M.H., Wisniewski, S.R., Nierenberg, A.A., Thase, M.E., Davis, L., Biggs, M.M., Shores-Wilson, K., Luther, J.F., Niederehe, G., Warden, D., Rush, A.J. The American journal of psychiatry. (2006)
- Adverse reactions to monoamine oxidase inhibitors. Part II. Treatment correlates and clinical management. Rabkin, J.G., Quitkin, F.M., McGrath, P., Harrison, W., Tricamo, E. Journal of clinical psychopharmacology. (1985)
- MAOIs in the contemporary treatment of depression. Thase, M.E., Trivedi, M.H., Rush, A.J. Neuropsychopharmacology (1995)
- Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression. Ketter, T.A., Post, R.M., Parekh, P.I., Worthington, K. The Journal of clinical psychiatry. (1995)
- Monoamine oxidase inhibitors allow locomotor and rewarding responses to nicotine. Villégier, A.S., Salomon, L., Granon, S., Changeux, J.P., Belluzzi, J.D., Leslie, F.M., Tassin, J.P. Neuropsychopharmacology (2006)
- Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro. Zhang, W., Kilicarslan, T., Tyndale, R.F., Sellers, E.M. Drug Metab. Dispos. (2001)
- In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor, trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene. Taavitsainen, P., Juvonen, R., Pelkonen, O. Drug Metab. Dispos. (2001)
- The N-demethylation of the doxepin isomers is mainly catalyzed by the polymorphic CYP2C19. Härtter, S., Tybring, G., Friedberg, T., Weigmann, H., Hiemke, C. Pharm. Res. (2002)
- Antidepressant drug treatment induces Arc gene expression in the rat brain. Pei, Q., Zetterström, T.S., Sprakes, M., Tordera, R., Sharp, T. Neuroscience (2003)
- Treatment of imipramine-resistant recurrent depression, IV: A double-blind crossover study of tranylcypromine for anergic bipolar depression. Thase, M.E., Mallinger, A.G., McKnight, D., Himmelhoch, J.M. The American journal of psychiatry. (1992)
- Amphetamine and tranylcypromine in an animal model of depression: pharmacological specificity of the reversal effect. Katz, R.J., Roth, K.A., Schmaltz, K. Neuroscience and biobehavioral reviews. (1981)
- Plasma tranylcypromine: relationship to pharmacokinetic variables and clinical antidepressant actions. Mallinger, A.G., Himmelhoch, J.M., Thase, M.E., Edwards, D.J., Knopf, S. Journal of clinical psychopharmacology. (1990)